meeting report 5th European HIV Drug Resistance Workshop

New Data on HIV and HBV Resistance to Antivirals
Report from the Fifth European HIV Drug Resistance Workshop
 
Written by Mark Mascolini
 
Clinical Implications of Resistance
An array of clinically focused Workshop studies bolstered evolving thinking in antiretroviral management, particularly the goal of striving for an undetectable viral load when planning regimens after multiple failures. One retrospective analysis figured that cumulative mutations—and certain individual mutations—have an impact on survival, while another study identified mutations that may foster sustained susceptibility to tipranavir. 



The complete meeting report of the 5th European HIV Drug Resistance is published in Reviews of Antiviral Therapy, volume 2- 2007. The report is accompanied by clincical comments written by Dr. J. Schapiro

A copy of the journal can be requested by sending an email to info@virology-education.com. The cost for the journal is:

• Workshop delegate: 45 Euro + postage costs
• Representative of a non-sponsoring company: 125 Euro + postage costs
• Representative of a workhop sponsoring company: only postage costs
• Representative of a Medical Information company: 125 Euro + postage